Drug Shortage Report for NEURONTIN
Report ID | 33933 |
Drug Identification Number | 02084260 |
Brand name | NEURONTIN CAP 100MG |
Common or Proper name | NEURONTIN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-02-14 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-02-06 |
Shortage status | Avoided shortage |
Updated date | 2018-02-07 |
Company comments | Please note that only 1 lot with an expiry date of 6/30/2018 remains available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2018-02-07 | French | Compare |
v13 | 2018-02-07 | English | Compare |
v12 | 2018-01-19 | French | Compare |
v11 | 2018-01-19 | English | Compare |
v10 | 2018-01-19 | English | Compare |
v9 | 2018-01-19 | English | Compare |
v8 | 2018-01-02 | French | Compare |
v7 | 2018-01-02 | English | Compare |
v6 | 2017-12-31 | English | Compare |
v5 | 2017-12-20 | French | Compare |
v4 | 2017-12-20 | English | Compare |
v3 | 2017-12-20 | French | Compare |
v2 | 2017-12-20 | English | Compare |
v1 | 2017-12-20 | English | Compare |
Showing 1 to 14 of 14